Vascular

Avantiss: innovation in biomaterials and diagnostics for high-performance implants.

What it is

C4C Vascular drives advanced technological solutions to enhance the safety, functionality, and durability of medical implants. Through initiatives such as Avantiss, focused on biomaterials with regenerative properties, and Arthopaint, an intraoperative diagnostic system, this division seeks to optimize implant integration with the human body and reduce postoperative complications. Its goal is to provide high-performance tools for more precise and personalized medicine.

Tecnología

At C4C Vascular, we develop high-performance technological solutions to improve the safety, functionality, and integration of medical implants. Through innovations such as Avantiss, using regenerative biomaterials, and Arthopaint, an intraoperative diagnostic system, we aim to optimize surgical outcomes, reduce complications, and advance toward more precise and personalized medicine.

Avantiss

Biofabricated implants, personalized and ready to use. It is our vascular platform that creates functional tissues tailored to each patient, combining cells, nanofibers, and 3D architecture in a unique robotic system. A transformative solution to replace damaged tissues with precision, speed and biocompatibility.

Solution

At C4C Vascular, we transform the design and performance of medical implants through advanced technological solutions. Through platforms such as Avantiss, we develop regenerative biomaterials and intraoperative diagnostic systems that improve implant integration, reduce complications, and extend functionality. It represents a commitment to more precise, safer and personalized medicine.

Vascular for Investors

Invest in biotechnology that is redefining reconstructive medicine. C4C Vascular represents a unique opportunity in innovation applied to medical implants, with technologies such as Avantis and Arthopaint, which enhance the integration, monitoring, and performance of orthopedic devices. With high scalability potential and global clinical applications, this platform drives a more precise, safe, and personalized form of medicine.